Acumen Pharmaceuticals Stock (NASDAQ: ABOS) stock price, news, charts, stock research, profile.
Open | $3.110 |
Close | $3.190 |
Volume / Avg. | 167.647K / 341.624K |
Day Range | 3.070 - 3.210 |
52 Wk Range | 1.810 - 11.310 |
Market Cap | $194.058M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 2.77% |
Days to Cover | 2.59 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Acumen Pharmaceuticals (NASDAQ: ABOS) through any online brokerage.
Other companies in Acumen Pharmaceuticals’s space includes: Zura Bio (NASDAQ:ZURA), Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT) and bluebird bio (NASDAQ:BLUE).
The latest price target for Acumen Pharmaceuticals (NASDAQ: ABOS) was reported by HC Wainwright & Co. on Wednesday, March 27, 2024. The analyst firm set a price target for 15.00 expecting ABOS to rise to within 12 months (a possible 364.40% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Acumen Pharmaceuticals (NASDAQ: ABOS) is $3.23 last updated April 25, 2024 at 6:17 PM EDT.
There are no upcoming dividends for Acumen Pharmaceuticals.
Acumen Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Acumen Pharmaceuticals.
Acumen Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.